医疗科技公司直觉外科发布2026年第二季度财报，营收达到28.9亿美元，同比增长18.5%，超出分析师预期2.6%。调整后每股收益2.80美元，较市场预期高出11.9%。运营利润率从去年同期的30.5%提升至33.6%，调整后运营利润率达到40.9%。 尽管业绩全面超预期，但公司股价在盘后下跌约11%，报357.2美元。主要原因是多家大型医疗机构报告手术量出现下滑，同时达芬奇手术系统部分组件被发出二级召回。
医疗科技公司直觉外科发布2026年第二季度财报，营收达到28.9亿美元，同比增长18.5%，超出分析师预期2.6%。调整后每股收益2.80美元，较市场预期高出11.9%。运营利润率从去年同期的30.5%提升至33.6%，调整后运营利润率达到40.9%。 尽管业绩全面超预期，但公司股价在盘后下跌约11%，报357.2美元。主要原因是多家大型医疗机构报告手术量出现下滑，同时达芬奇手术系统部分组件被发出二级召回。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.